HOME >> BIOLOGY >> NEWS
Drug decreases blood vessel stiffness in older primates

A novel drug that breaks down vascular collagen bonds in the body significantly decreased the stiffness of blood vessels in older non-human primates, according to a study conducted by National Institute on Aging (NIA) scientists and others.* The finding suggests the medication could be a new treatment for high blood pressure, heart failure, and certain vascular complications of diabetes.

ALT-711 (Alteon, Ramsey, New Jersey), a thiazolium-based compound, snips bonds or crosslinks created in the arteries and other tissues when glucose attaches to collagen. Crosslinks are cable-like structures that inhibit the natural flexibility of collagen strands. They tend to proliferate with age. Crosslinks appear to toughen tissues and may cause some of the deterioration associated with aging and diabetes, such as elevated systolic blood pressure, hardened arteries, and impaired kidney function.

In the study, six rhesus monkeys received doses of ALT-711 every other day for three weeks. Six weeks after the last treatment, all of the vessel walls tested were more flexible, and the effect persisted for more than four months after final administration of the drug. Blood flow through the heart also increased and this improvement persisted for nearly 10 months after the treatments ended. No significant changes in body weight or routine chemical measurements were detected during the follow-up period. The finding was published in the January 30, 2001 issue of Proceedings of the National Academy of Sciences.

Arterial stiffening is a major factor in many of the vascular diseases associated with advancing age, said Edward Lakatta, M.D., co-author of the study and chief of the NIAs

Laboratory of Cardiovascular Sciences. The significance of this drug is it alters the properties of the arterial wall and makes it easier for the heart to eject blood into the blood vessels. These results, coupled with prior studies in smaller animals, certainly suggest that
'"/>

Contact: Doug Dollemore
dollemod@nia.nih.gov
301-496-1752
NIH/National Institute on Aging
29-Jan-2001


Page: 1 2

Related biology news :

1. Breastfeeding decreases infant mortality
2. Complement inhibitor decreases heart attacks and death in men following cardiac surgery
3. Sepsis drug fights infection, decreases hospital care over two year study
4. Rock climbing decreases biodiversity
5. New study of healthy men finds semen quality decreases with age
6. Smoking decreases mens chances of fatherhood by IVF and ICSI
7. Estrogen receptor-{alpha} antisense decreases brain estrogen receptor levels and affects ventilation in male and female rats
8. Experimental drug decreases age-related blood vessel stiffening
9. Meditation decreases blood pressure
10. Experimental drug shown to block mutant protein causing blood disease
11. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2019)... ... September 25, 2019 , ... LeadingBiotech ... and dialogue, today announces its inaugural South CEO conference to be ... , Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives to ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... interactions for accelerated drug development, announced today that it has raised $2.8M from ... OS Fund and also includes AME Cloud Ventures, Boom Capital, Madrona Venture Group, ...
(Date:9/17/2019)... ... September 17, 2019 , ... Last week, Blackrock Microsystems, ... from the Medical University of Warsaw, met at the Presidential Palace of the ... a neuroprosthetic system as part of an initiative called "Startups in the Palace ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has ... October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. ... several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company Asymmetrex ... Like the company’s precursor patent, approved in the U.S. in 2017, the new patent ... Asymmetrex now markets the technology in the U.S. as the AlphaSTEM Test™. ...
(Date:10/3/2019)... Calif. (PRWEB) , ... October 02, 2019 , ... ... business opportunity to investors and venture capital companies in Silicon Valley at a special ... 8:30 pm. The event will be held at the JJ Lake Business Center located ...
(Date:9/30/2019)... ... September 30, 2019 , ... The September ... Rigaku Corporation , is now available online on the company’s global website. The ... including X-ray diffraction, fluorescence and imaging, and presents articles, scientific papers and news ...
Breaking Biology Technology:
Cached News: